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sustainable bioconversion of plant-derived carbohydrates into solvents, such as
butanol or acetone. However, relatively few strains have been extensively
characterised either at the genomic level or through exemplification of a
complete genetic toolkit. To remedy this situation, a new strain of C.
beijerinckii, NCIMB 14988, is selected from among a total of 55 new clostridial
isolates capable of growth on hexose and pentose sugars. Chosen on the basis
of its favorable properties, the complete genome sequence of NCIMB 14988 is
determined and a high-efficiency plasmid transformation protocol devised. The
developed DNA transfer procedure allowed demonstration in NCIMB 14988 of
the forward and reverse genetic techniques of transposon mutagenesis and
gene knockout, respectively. The latter is accomplished through the successful
deployment of both group II intron retargeting (ClosTron) and allelic exchange.
In addition to gene inactivation, the developed allelic exchange procedure is
used to create point mutations in the chromosome, allowing for the effect of
amino acid changes in enzymes involved in primary metabolism to be
characterized. ClosTron mediated disruption of the currently unannotated non-
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Alongside the notorious pathogens Clos-
tridium difﬁcile, Clostridium tetani, and
Clostridium botulinum among others, the
genusClostridium containsmanymembers
capable of industrially useful biological
conversions between varied substrates and
products. The saccharolytic mesophiles
Clostridium beijerinckii, Clostridium aceto-
butylicum, and Clostridium saccharobutyli-
cum are able to convert sugar into the
solvents acetone, butanol and ethanol, with
industrial scale acetone production wide-
spread during the early twentieth century.[1]
After the demise of commercialClostridium
fermentations in the latter part of the 20th
century due to reduced oil prices, Clostrid-
ium strains are again being commercial-
ized by companies such as LanzaTech and
Green Biologics Ltd. As genome sequences
of saccharolytic Clostridium strains have
become available, historical isolates, in-
cluding those used in industrial acetone-
butanol-ethanol (ABE) fermentations, have
been reclassiﬁed, often as C. beijerinckii.[2,3]Additional substrates that may be utilized by various
Clostridium species include steel mill waste gases, pre-treated
waste lignocellulosic material, and waste glycerol.[4–6] Other
fermentation by-products can include acetate, butyrate, hydro-
gen, 2,3-butanediol and isopropanol.[7,8] A spo0A mutant of C.
beijerinckiiNCIMB 8052, in combination with the enzyme lipase,
is capable of the production of butyl butyrate.[9]
Previously, solvent-producing clostridia have been isolated
from various sources, including potatoes, leguminous plant
roots, manure, garden, and agricultural soils, cereal crops,
gooseberries, river bottom mud, decayed wood, and a putrefying
clam.[10–13] However, no butanol-producing Clostridium has yet
been isolated that is capable of growth on lignocellulosic
material. To address this, genetic engineering and consolidated
bioprocessing are a promising approach, for example the
expression of glycoside hydrolases in C. beijerinckii NCIMB
8052[14] or a dual culture of engineered Clostridium cellulovorans
DSM 743B and C. beijerinckii NCIMB 8052.[15]
Despite the catalytically diverse properties of the genus
Clostridium, exploitation of their full biotechnological potentialnal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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genetically manipulate in comparison to Gram-negative organ-
isms such as E. coli. In the past decade advances have beenmade
in the development of techniques for forward and reverse genetic
engineering in the Clostridium. Reverse genetic tools such as
ClosTron gene inactivation[16] or in-frame deletions using Allele
Coupled Exchange (ACE) with a heterologous pyrE allele as a
counter selection marker[17] have streamlined the process of
creating knock-outs. Random mutagenesis using a mariner-
based transposon system has been described in C. difﬁcile, C.
acetobutylicum, and Clostridium sporogenes.[18,19]
We have recently described a guide, or “roadmap” for
application of these foundational genetic tools to additional
Clostridium species.[20] To demonstrate its utility, here we isolate
a novel solventogenic Clostridium strain from the environment
and then demonstrate application of the roadmap.2. Experimental Section
2.1. Media, Strains, and Growth Conditions
Reagents were purchased from Sigma–Aldrich (UK), unless
otherwise noted. Clostridium spp. were cultivated at 37 C in an
anaerobic cabinet (Don Whitely, UK) using CBM,[21] 2xYTG
(16 g L1 tryptone, 10 g L1 yeast extract, 5 g L1 NaCl, 5 g L1
glucose) or CGMmedia,[22] supplemented with antibiotics when
required. Typical antibiotic concentrations for Clostridium spp.
are erythromycin 20 μgmL1, thiamphenicol 20 μgmL1, tetra-
cycline 10 μgmL1, spectinomycin 250 μgmL1. E. coli strains
TOP10 and DH10B (Thermo, UK) were grown at either 30 C or
37 C using LB media, supplemented with antibiotics where
necessary. For growth of pyrE mutants, media were supple-
mented with 50 μgmL1 uracil. For counter-selection of
plasmids containing the pyrE gene, 5-Fluoroorotic acid
(5’FOA) at a concentration of 800 μgmL1 prepared from a
stock of 150mgmL1 dissolved in DMSO was added to media.
The C. beijerinckii NCIMB 14988 pyrE strain can be obtained
from https://customers.chainbiotech.com.2.2. Isolation of Spore Forming, Saccharolytic Bacteria
Samples including soil, rotting material, and stagnant
water were added to anaerobic CBM broth containing either
6% (w/v) xylose or soluble starch before heat-shock at 70 C for
10min. After 24 hr incubation, growth was sub-cultured onto
CBM xylose agar plates. Colonies were then sub-cultured
twice on CBM xylose agar to obtain pure colonies. Single
colonies were used to inoculate 250 μL of CBM arabinose
broth. Cultures that grew were checked for growth on 6%
glucose (w/v) CBM agar plates. 16S rRNA was ampliﬁed from
genomic DNA by PCR using primers 27F and 1492R. Products
of metabolism were quantiﬁed using a Thermo Focus GC as
described previously,[23] with the exception that 5mL 10M
H2SO4 was added for acidiﬁcation, propyl-propionate was
used for extraction of solvents and 50mM valerate was added
as an internal standard.Biotechnol. J. 2018, 1700711 1700711 (2 of 9) © 2018 The2.3. Genome Sequencing and Annotation
Genomic DNA was prepared from a sporulation-deﬁcient
mutant containing an off-target ClosTron insertion (described
in this paper) by phenol-chloroform-isoamyl alcohol extraction
and sequenced by the McGill University and Genome Quebec
Innovation Centre, using two SMRT cells of a PacBio RSII
sequencer. The wild-type genome sequence was obtained by
mapping Illumina reads from the wild-type strain[24] to the
PacBio unitig, removal of the ClosTron RAM sequence and
generation of a consensus sequence.
The genome sequence was annotated using the NCBI
prokaryotic genome annotation pipeline. Infernal was used
for ncRNA detection,[25] Ori-Finder for oriC detection,[26] and the
resistance gene identiﬁer from the comprehensive antibiotic
resistance database[27] was used to identify antibiotic resistance
genes. CRISPRFinder[28] was used for the detection of CRISPR
sequences. A protein model of ptb was obtained from SWISS-
MODEL.[29] Amino acid conservation for residues 122 and 174 of
ptb was calculated using ConSurf[30] using both an automatically
generated sequence alignment of 150 UniRef90 sequences and
132 manually selected Clostridium sequences from the NCBI
non-redundant database.2.4. Construction of Plasmids
Enzymes were purchased from NEB (UK) and ThermoFisher
(UK). ClosTron plasmids with intron sequences retargeted to the
genes of interest were designed using the design tool at http://
www.clostron.com. The 350 bp retargeted sequences were
synthesised and cloned via BsrGI and HindIII restriction sites
of plasmid pMTL007C-E2 by DNA 2.0 (USA) as described by
ref. [16].
Asymmetric homology arms for the partial deletion of the
pyrE gene of C. beijerinckii were generated by PCR using primers
59B_pyrE_LHA_F (SbfI) and 59B_pyrE_sLHA_R (NotI) and
59B_pyrE_RHA_F (NheI) and 59B_pyrE_RHA_R (AscI)
(Table S1, Supporting Information). The PCR products were
cloned into plasmid pMTL83151 (pCB102 frame-shift repli-
con[31]) to give plasmid pMTL-GL12. The pyrE correction cassette
for the ACE correction vector pMTL-GL6 was constructed by
PCR using primers 59B_pyrE_LHA_F and 59B_pyrE_RHA_R.
The full length LHAs for complementation and over-expression
vectors were generated using primers 59B_pyrE_LHA_F and
59B_pyrE_lLHA_R. The MCS regions for pMTL-GL6C and 6X
were taken from pMTL-ME6C and 6X, respectively.[32] To create
suicide vectors lacking a Gram-positive replicon, plasmids were
digested with AscI and FseI, blunt-ends created with T4 DNA
polymerase, then backbone ends ligated together with T4 DNA
ligase. The suicide version of plasmid pMTL-GL12 was
designated pMTL-GL13; suicide versions of plasmids pMTL-
GL6, 6C and 6X were named pMTL-GL7, 7C, and 7X,
respectively.
Allele exchange cassettes for the in-frame deletion of genes
spo0A and ctfAB (59B-spo0A-KO and 59B-ctfAB-KO respectively),
were synthesized by MWG Operon (Germany). These 1.5 kbp
cassettes are constructed from the 750 bp upstream andAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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codons of the gene. The fragments were cut with NotI and
BamHI, and cloned into the plasmid pMTL-ME3::Cac-spo0A-KO,
to give plasmids pMTL-ME3-59B-spo0A-KO and pMTL-ME3-
59B-ctfAB-KO. Suicide versions of these vectors were created to
give plasmids pMTL-GL3-59B-ctfAB-KO and pMTL-GL3-59B-
spo0A-KO.
The ctfAB (LF65_04318/LF65_04319) genes, plus 211 bp
upstream, were ampliﬁed from genomic DNA using primers
ctfAB_cloning_F1 and ctfAB_cloning_R2 for insertion into
pMTL-GL7C/X (NdeI/BamHI). For construction of pMTL-
GL7C-Pald-ctfAB the ald promoter was ampliﬁed from C.
beijerinckii using primers Pald-NotI-F1 and Pald-R1; the ctfAB
genes were ampliﬁed using primers CtfRBS-AseI-F1 and
ctfAB_R1-NheI; the fragments were cloned into the plasmid
using the enzymes NotI, AseI, and NheI.
The genes ctfAB were cloned behind the tcdB promoter of C.
difﬁcile taken from vector pJ204:BB2-WOK015, into plasmid
pMTL82151, using NEBuilder HiFi, using primer pairs 1)
82151/PtcdB-NotI & ctfAB/PtcdB and 2) PtcdB/ctfAB & 82151/
ctfAB, to give plasmid pMTL82151-tcdB-ctfAB.
Plasmids for the introduction of point mutations into the ptb
gene were constructed using the following primers, A:
pMTL_GL3 (template) with G_plasmid_rev and plasmid_fd_ﬁx.
B: 59B gDNA with G_ptb_fd and G_M122I_rev. C: 59B gDNA
with G_M122I_fd and G_DraI_rev. D: 59B gDNA with
G_DraI_fd and G_I174V_rev. E: 59B gDNA with G_I174V_fd
and ptb_rev_ﬁx. F: 59B gDNAwith G_ptb_fd and G_DraI_fd. G:
59B gDNA with G_DraI_fd and ptb_rev_ﬁx. Plasmids were
constructed as follows: pMTL_GL3_59B_ptb_M122I_I174V¼A
þBþCþDþE; pMTL_GL3_59B_ptb_M122I¼AþBþCþF;
pMTL_GL3_59B_ptb_I174V¼AþGþDþE;
pMTL_GL3_59B_ptb_DraI¼AþFþG.2.5. Transformation with DNA
Conjugations were conducted as previously described[33] with E.
coli CA434 as a conjugation donor strain. A protocol for
electroporation of C. beijerinckii was developed based on
previously published methods.[34,35] Exponentially growing
culture was used to inoculate 300mL 2xYTG broth. Once the
OD (600 nm) had reached 0.2, cells were washed twice in
decreasing volumes of ice cold SEB buffer (Sucrose 270mM,
Na2HPO4 7mM, NaH2PO4 7mM, MgCl2 1mM), before
resuspension in 10% DMSO SEB. 280 μL aliquots of cells were
frozen at80 C. Cells were transformed with 1 μg of plasmid in
a 0.2 cm electroporation cuvette, with a 1.25 kVexponential pulse
(200Ω resistance and 25 μF capacitance). Cells were immediately
recovered in 3mL 2xYTG at 37 C for 3 hr, before spreading on
the appropriate selective plate.2.6. Replicon Stability Assay
The replicon stability of the pMTL80000 clostridial modular
vectors and the pCB102 frame-shift replicon pMTL83151[31]
were tested in C. beijerinckii as described in ref. [33]. These
replicons were in the context of pMTL8-151 (catP, ColE1þ tra,Biotechnol. J. 2018, 1700711 1700711 (3 of 9) © 2018 TheMCS). To conﬁrm that the pCB102 frame-shift plasmid was the
correct sequence, it was isolated from C. beijerinckii using a
GenElute plasmid miniprep kit, transformed into E. coli TOP10,
puriﬁed by miniprep and sent for sequencing using primers
pCB102_311_F and pCB102_1616_R.2.7. Southern Blotting
Southern blotting was conducted using a digoxigenin (DIG)
High-Prime DNA labelling and detection kit (Roche,
Switzerland) as per the manufacturer’s instructions, using the
following protocol described previously[36]. Labeled probes for
the ClosTron insertion were prepared by PCRwith primers EBS2
and SalI-R1 using ClosTron plasmid as template. Genomic DNA
was digested with HindIII.2.8. Inverse-PCR
The genomic context of intron and transposon insertions into
the chromosome was determined by inverse PCR as described
previously by ref. [18], with the exception that Phusion DNA
polymerase was used for PCR reactions. The restriction enzyme
SmiI and primers E2_inv_F and E2_inv_R were used for inverse
PCR of the spoVT ClosTron mutant.3. Results
3.1. An Isolation Procedure Specific to Clostridium
beijerinckii
Of 150 environmental samples screened for Clostridium species
(see section 2.2), 55 contained spore formingmesophiles capable
of growth on both hexose and pentose sugars. The 16S rRNA
genes for the initial 24 isolated bacteria had at least 99% identity
to C. beijerinckii NCIMB 8052, the type strain of C. beijerinckii.
The isolates fermentatively produced butanol at concentrations
of 3–71mM, acetone at 0–40mM, and approximately 3mM
ethanol. The sensitivity of the isolated bacteria to the antibiotics
erythromycin, lincomycin, thiamphenicol, tetracycline, and
spectinomycin was determined by plating the bacteria on media
supplemented with each antibiotic (data not shown). Tolerance
of growth in the presence of 0.5% and 1% butanol of the 11
highest butanol-producing isolates were measured alongside a
C. beijerinckii NCIMB 8052 control, with 3 of the isolates
showing an inability to grow in broth containing 0.5% butanol
(Figure S1, Supporting Information). Strain 59B, which was
isolated from garden soil by screening with media containing
starch, showed good butanol production characteristics, sensi-
tivity to a range of antibiotics and a level of butanol tolerance
comparable to C. beijerinckii NCIMB 8052 (Figure S1 and
Table S4, Supporting Information). This strain was deposited in
the NCIMB culture collection and given the strain designationC.
beijerinckii NCIMB 14988. In contrast to C. beijerinckii NCIMB
8052, it is sensitive to thiamphenicol, which is useful as it allows
the catPmarker gene to be used for genetic manipulation of this
strain.Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Read Data
The gaps present in the previously described genome sequence
forC. beijerinckiiNCIMB 14988[24] were closed using PacBio long
read sequencing. The complete genome sequence consists of
6 485 394 nucleotides, with 5670 annotated genes and a GC
content of 30% (Figure 1). There are 17 copies of 5S rRNA genes
and 16 16S and 23S rRNA genes, 93 tRNAs, 99 ncRNAs, 341
signal peptides and 97 pseudogenes. No methylation motifs
were detected in the PacBio sequencing data. The genome
sequence does not appear to encode any restriction-modiﬁcation
systems, although the gene LF65_01813 shows similarity to a N-
6 DNAmethylase and gene LF65_02681 encodes a putative Type
IV methyl-directed restriction enzyme of unknown recognition
sequence. The oriC replication origin was identiﬁed as a 693 bp
region at location 6470506-6471198 immediately upstream of
dnaA (LF65_05786). Although 24 antibiotic resistance genes
including potential rifampicin, fosfomycin, aminocoumarin and
mupirocin systems were detected, no genes encoding resistance
to any of themarkers in the pMTL80000modular vector series[33]
were identiﬁed.
There exists in the genome sequence one complete and one
incomplete phage, as identiﬁed by PHASTER.[37] The complete
phage spans a 38 kbp region between nucleotides 2498353-
2536373, coding for 40 proteins, of which 9 are hypothetical. The
ﬁrst gene in the sequence, LF65_02259 encodes a phage C-5
cytosine-speciﬁc DNA methylase. The incomplete phage con-
sists of nine proteins spanning a 24.7 kbp region between
nucleotides 6292563-6317281, of which 3 are hypothetical. Three
further regions containing phage sequences were identiﬁed byFigure 1. Circular diagram of the genome sequence of C. beijerinckii
NCIMB 14988 (GenBank ref. CP010086.2). Tracks (from outside
inwards): forward CDS; reverse CDS; rRNA (gray) and tRNA (green);
GC plot (Black: above average; Purple: below average); GC skew (Orange:
below average; Green: above average). Image created using DNAPlotter
1.11.[56]
Biotechnol. J. 2018, 1700711 1700711 (4 of 9) © 2018 TheProphinder[38] at locations 4234897-4250743, 5848557-5880612,
and 5924611-5936402. The genome contains 45 genes annotated
as transposases. There exists a CRISPR of 205 bp length at
location 1340091-1340296 but this does not appear to encode any
associated proteins. IslandViewer3[39] predicts the presence of 25
genomic islands which may contain horizontally obtained DNA
sequences, the smallest of which is 4123 bp and the largest
2 9183 bp. None of these contain pathogenicity loci.
A large amount of the genome sequence is involved in the
manipulation of carbohydrates, with 965 of the 5425 protein
coding genes (17.8%) having glycosidic bond activity based on
similarity to proteins in the CAZy database.[40] No genes
encoding cellulases that would enable growth on lignocellulosic
material are present in the genome sequence.3.3. Development of a High Efficiency Transformation
Protocol
Historically it has been difﬁcult to introduce foreign DNA into
Clostridium. The development of an efﬁcient and reproducible
transformation protocol is essential for metabolic engineering in
this genus. A detailed description of the process of trouble-
shooting genetic transfer in clostridia has been published.[41]
Manipulation of some of the variables involved in the
preparation of electro-competent C. beijerinckii NCIMB 14988
cells enabled transformation with plasmid pMTL85151[33] at
efﬁciencies of approximately 1 105 cfu μg1 DNA (see section
2.5), which is high enough to allow for the use of suicide
plasmids. Adding DMSO to a ﬁnal concentration of 10% to the
washed cells as a cryoprotectant facilitated the storage of
the electro-competent cells at 80 C for at least 2 years, with
no impact on electroporation frequencies. This suggests that
C. beijerinckii NCIMB 14988 is tolerant of brief exposure to
oxygen as documented in C. beijerinckii NRRL B-598.[3]3.4. Gram-Positive Replicon Stability
For some applications it is useful to have available a “pseudo-
suicide” vector with low replicon stability. To this end, the replicon
stabilityof theGram-positive repliconsavailable in thepMTL80000
modular vector series,[33] in addition to a pCB102 frame-shift
replicon,[31] were tested inC. beijerinckiiNCIMB14988. After 24hr
the percentages of colonies retaining plasmid were as follows:
pBP1, 99.5%; pCB102, 49.2%; pCB102(FS), 100%; pCD6, 14.3%;
pIM13, 97.7%. These data indicated that the pCB102 replicon,
used in the most commonly employed ClosTron vectors, was
sufﬁciently unstable to allow efﬁcient plasmid loss.3.5. Knock-Out of Genes Using ClosTron Insertional
Mutagenesis
The methods described in this study rely upon the ability to
reversibly truncate the pyrE gene (LF65_01058, orotate phosphor-
ibosyltransferase) as described previously.[17] In order to conﬁrm
that the pyrE gene could be knocked-out, and that mutants
would be unable to grow onmedia lacking uracil, the pyrE gene ofAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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technology. The desired gene disruption delivered by plasmid
pMTL007C-E2-pyrE-486a was conﬁrmed by PCR using primers
76_F and 3651_R (not shown). Wild-type and pyrE- mutants were
sub-cultured onto CBM plates containing 5’FOA, erythromycin
anduracil to conﬁrm that the pyrE disruption confers resistance to
5’FOA.Conﬁrmation that themutantscontainedasingle insertion
of the intronwas obtained by Southern blotting (not shown). After
several passages in non-selective broth, the pyrE- mutant was
checked for plasmid loss by plating onto a CBM plate containing
5’FOA, thiamphenicol and uracil.
To further exemplify the ClosTron, the NCIMB 14988 wild-
type strain was transformed with pMTL007C-E2 plasmids
retargeted for the knock-out of the genes spoIIE
(LF65_00124), spoVT (LF65_00110) and spo0A (LF65_01851).
For the plasmid targeting spo0A, no erythromycin resistant
colonies were obtained. Thiamphenicol sensitive/erythromycin
resistant colonies were obtained for the spoIIE and spoVT knock-
outs, which when viewed using light microscopy showed no
spore formation. Heat shock with 80 C for 10min of 1mL of
overnight cultures before spreading 100mL onto CGM plates,
gave colony counts of 2, 13, and 174 for spoIIE, spoVT and wild-
type, respectively. PCR with ﬂanking primers (spoIIE_F/R and
spoVT_F/R) conﬁrmed the insertion of the RAM into the spoIIE
gene, but revealed the absence of an insertion in the spoVTgene,
suggesting an off-target insertion had occurred. Sequencing by
inverse-PCR using primers to the RAM could not be placed
accurately into the draft genome sequence. The precise location
of this insertion was obtained by PacBio long-read sequencing
and was found to be in a region densely populated with rRNA
genes, between genes LF65_05915 and LF65_05920 at location
902390-902391. When repeated in a pyrE mutant the same
location was disrupted with the same resultant phenotype. An
analysis of the intergenic region (706 bp) with RNAstructure[43]
predicts the presence of several stem-loop structures.Figure 2. Circular plot of locations ofmariner transposon insertions in the
C. beijerinckii NCIMB 14988 genome identified using inverse-PCR and
Sanger sequencing. Insertions shown on the inside of the genome are in
the opposite strand to those on the outside.3.6. Genome Integration of Genes at the pyrE Locus Using
ACE
The pyrE gene was truncated to create a mutant that would
enable integration of heterologous DNA at the pyrE locus using
ACE.[17]C. beijerinckiiNCIMB 14988 cells were transformed with
suicide plasmid pMTL-GL13. This plasmid, based on pMTL-
JH12, contains a short homology arm of codons 40-340 of the
pyrE gene and a long homology arm of 1199 bp immediately
downstream of pyrE. Truncation of pyrE was conﬁrmed with
ﬂanking primers 274_F & 4652_R and sequencing using
primers 59B_pyrE_1090R and 59B_pyrE_37F.
Plasmid pMTL-ME2,[31] containing the C. sporogenes ATCC
15579 pyrE gene downstream of the catP gene, was used for
functional complementation of the pyrE knock-out. MIC values
for 5’FOA were determined for the wild-type by plating out onto
CBM plates containing 15 μgmL1 uracil and 0–2mgmL1
5’FOA. Colonies grew on the control plates, with some single
colony growth observed at 200 μgmL1, limited growth at
400 μgmL1 and no growth observed at 600 μgmL1 or above.
Electro-competent pyrE cells were reverted to pyrEþ with
suicide “pyrE correction” and complementation plasmidsBiotechnol. J. 2018, 1700711 1700711 (5 of 9) © 2018 ThepMTL-GL7 and pMTL-GL7C, respectively. The corrections were
conﬁrmed by PCR with primers 274_F and 4652_R.
The ability to integrate heterologous DNA at the pyrE locus
using ACEwas exempliﬁed by the integration of the sigma factor
tcdR, allowing for the expression of genes in the C. beijerinckii
NCIMB 14988 strain from the C. difﬁcile tcdB promoter. The tcdR
gene from C. difﬁcile was obtained by digestion of pMTL-ME6C-
tcdR[19] with NotI and BamHI enzymes, and subsequent ligation
into pMTL-GL6C digested with the same enzymes, to create
pMTL-GL6C-tcdR. The suicide version of this vector was
designated pMTL-GL7C-tcdR. Growth curves of both C.
beijerinckii::tcdR and wild-type were measured to conﬁrm that
the expression of tcdR from the chromosome had no effect on
the growth of the organism (Figure S2, Supporting Information).3.7. Forward Genetics Using a Mariner Transposon
Screening randomly generated mutants for interesting pheno-
types in a forward genetics approach provides important,
sometimes counter-intuitive information regarding which genes
are involved. A suicide version of mariner transposon plasmid
pMTL-SCI[18] was created by removal of the Gram-positive
replicon, to create plasmid pMTL-GL15. This plasmid expresses
the himarI C9 transposase gene from the C. difﬁcile tcdB
promoter, and as such is only expressed in a tcdRþ background.
Single colonies of tcdRþ transformed with pMTL-GL15 were
picked and genomic DNA extracted from 48 for inverse PCR
using HindIII digestion and PCR with primers CatP-Inv-F1 and
CatP-Inv-R1. PCR products were sequenced with primer catP-
INV-R2. The locations of 37 transposon insertions into the
genome were calculated, and are shown in Figure 2.Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Genes
Having a pyrEmutant created using ACE in the NCIMB 14988
strain allowed for the marker-less, in-frame deletion of genes,
followed by chromosomal complementation at the pyrE locus.
The genes ctfAB and spo0A were chosen as targets based on
published accounts of their successful knock-out in clos-
tridia.[23,42] Suicide plasmids pMTL-GL3_59B_ctfAB-KO and
pMTL-GL3_59B_spo0A-KO were constructed based upon the
design of suicide knock-out plasmid pMTL-ME3.[32] Competent
pyrE- cells were transformed before recovery and plating onto
CBM plates with thiamphenicol selection. The average colony
counts were 44 and 25 at 101 dilution for pMTL-
GL3_59B_spo0A-KO and pMTL-GL3_59B_ctfAB-KO, respec-
tively. Single colonies were picked, genomic DNA was extracted
and PCR conducted with one primer to the chromosome
(ctf_downstream/spo0A_downstream) and one primer to the
plasmid (M13F(21)) to conﬁrm integration of the plasmid.
Single crossovers were plated out on 5’FOA containing plates
and colonies picked for screening for double crossovers with
ﬂanking primers, which revealed a mixture of wild-type and
knock-out colonies. Colonies that were ctfABwere sub-cultured
to purity and plasmid loss was conﬁrmed. Colonies that showed
a deletion of spo0A were unable to grow when sub-cultured.
The truncated pyrE gene of the pyrEctfAB mutant was
corrected back to wild-type using plasmid pMTL-GL7, restoring
uracil prototrophy. Analysis of solvent and acid production in the
ctfAB-mutant revealed that acetone formationwaseliminated, at the
expense of increased acetate production and decreased butanol
formation (Figure 3).
In commonwithall knownC.beijerinckii,Clostridiumpuniceum,C.
saccharobutylicum and Clostridium saccharoperbutylacetonicum, the
ctfAB genes of C. beijerinckii NCIMB 14988 reside in a type II sol
operon,[2] starting with the ald gene LF65_04317 (aldehydeFigure 3. Solvent and acid production of C. beijerinckii NCIMB 14988
ctfABmutants, grown in 30mL cultures. Blue: wild-type strain. Red: ctfAB
knock-out. Green: ctfAB knock-out, chromosomal complementation at
pyrE locus with ctfAB genes plus 211 bp upstream. Purple: ctfAB knock-
out, chromosomal complementation at pyrE locus with ctfAB genes
expressed from C. sporogenes fdx promoter. Orange: ctfAB knock-out,
chromosomal expression of tcdR gene at pyrE locus, plasmid expression
of ctfAB genes from tcdB promoter. Gray: ctfAB knock-out, chromosomal
complementation at pyrE locus with ctfAB genes expressed from ald
promoter. Gold: as gray, with complementation plasmid still present.
Error bars show standard deviation.
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246bpof theregionupstreamofthealdRBSwasinsertedupstreamof
the ctfABgenes (with their nativeRBS) in chromosomal complemen-
tation plasmid pMTL-GL7C-Pald-ctfAB. The ctfAB genes plus a small
stretch of upstream sequencewere cloned into plasmid pMTL-GL7C
for promoter-less complementation, and plasmid pMTL-GL7X for
expression from the fdx promoter from C. sporogenes.
Clean integration of ctfAB from plasmids pMTL-GL7C-ctfAB,
pMTL-GL7X-ctfAB, and pMTL-GL7C-Pald-ctfAB failed to restore
solvent production to wild-type levels. One colony with an
integration of pMTL-GL7C-Pald-ctfAB that still retained the
plasmid showed a nearly complete complementation of solvent
production (Figure 3).
It was known from the expression of genes using theC. difﬁcile
sigma factor tcdR (as described earlier) that the tcdB promoter
could be used in this strain for the expression of genes. The vector
pMTL-GL7C-tcdR was used to correct the pyrE phenotype of the
ctfABpyrEmutant to give a ctfAB-tcdRþmutant. The ctfAB genes
were expressed in this strain from the tcdB promoter and RBS
(ribosome binding site) on plasmid pMTL8215-tcdB-ctfAB. The
presence of this plasmid restored the solvent production back to
wild-type levels (see Figure 3). This conﬁrmed that it was possible
to complement the mutant and that the observed changes in
phenotype were caused by the ctfAB KO.3.9. Creating Chromosomal Point Mutations
The roadmap enables the targeted introduction of point mutations
into the genome.Analysis of historical industrial butanol producing
strains suggests that the amino-acid substitution M122I in the
phosphate butyryltransferase (ptb) enzyme (Figure 4a) results in a
reduced activity.[2] Compared to other Clostridium spp. ptb
sequences, C. beijerinckii NCIMB 14988 has the rare substitution
V174I (seeTableS5, Supporting Information). To testwhether these
substitutions inﬂuence solvent production, SNPs were introduced
into the ptb gene of C. beijerinckii NCIMB 14988 (LF65_00241,
909bp) to give M122I and I174V mutations. Suicide plasmids
pMTL_GL3_59B_ptb_M122I_I174V, pMTL_GL3_59B_ptb_M122I,
pMTL_GL3_59B_ptb_I174V and pMTL_GL3_59B_ptb_DraI were
created for the silent removal (that is, using synonymous codon
substitutionwithno impact on the sequenceof the encodedprotein)
of a DraI site (TTTAAA>TTTAAG) present in the coding sequence
of ptb, alongside the required point mutations to allow for easy
identiﬁcation of successful integration events based on restriction
digestion of PCRproductswithDraI (see section 2.4). The plasmids
were transformed into the pyrE mutant and double homologous
recombination events conﬁrmed by PCR and Sanger sequencing.
The pyrE phenotype was corrected to uracil prototrophy using
plasmid pMTL-GL7. Solvent production was measured using GC
from 30mL batch cultures. No changes in solvent production were
observedbetween thepointmutations and theDraI silenced control
(Figure S3, Supporting Information).4. Discussion
In this studywehaveexempliﬁed theutility ofour clostridial gene tool
roadmap[20] through the de novo isolation of a new strain of C.Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
Figure 4. A) A predicted model of the ptb protein dimer from C. beijerinckii NCIMB 14988
creating using SWISS-MODEL based on the Lmo1369 protein of Listeria monocytogenes.
Protein image created using QuteMol.[57] B) Amino acid conservation at residues 122 and
174 in the ptb gene in both 150 aligned UniRef90 sequences, and 132 Clostridium
sequences.
Table 1. Characteristics of the genetic tools used in this study
ClosTron
Integration of genes at pyr
locus using ACE
Forward/Reverse Reverse Reverse
Allows integration
of genes
Small amount of cargo Yes
Insertional
mutagenesis
Yes N/A
Repeated
insertions/
Deletions
Difficult Yes
Speed Quick Moderate
Background strain
required
No pyrE
Specific issues Off-target insertions can occur; Requires sensitivity to
thiamphenicol/erythromycin or spectinomycin
MIC testing of 5’FOA
required
www.advancedsciencenews.com www.biotechnology-journal.com
Biotechnol. J. 2018, 1700711 1700711 (7 of 9) © 2018 The Authors. Biotechnologybeijerinckii and the application of the roadmap to
put in place methods for forward and reverse
genetics. The characteristics of the genetic tools
described in this paper are shown in Table 1.
Recently the use of the CRISPR/Cas9 system has
been described in C. beijerinckii NCIMB 8052,[44]
which further expands the toolkit available for
manipulation of members of the Clostridium,
although further work would be required for its
use in C. beijerinckii NCIMB 14988. Whilst our
intention was not to only isolate members of this
species, out of 55 isolates no other saccharolytic
specieswasobtained.Clearly theselectionmethod
used is speciﬁc forC. beijerinckii, and could prove
useful to others who wish to isolate new
representatives of this species. Here wewere able
to derive a complete sequence of the genome
using PacBio sequencing, making it the sixth
representative of C. beijerinckii for which a closed
genome is available.[2,3,45]
No active methylation systems were identi-
ﬁed, which obviated the need to create systems
for either the methylation of vectors, or the
deletion of restriction-methylation systems, as
described in C. acetobutylicum.[46] Accordingly,
it proved possible to introduce plasmid DNA
into the strain at high frequencies by
electroporation, paving the way for the use
of suicide plasmids.
During the roadmap exempliﬁcation pro-
cess it proved possible to make an in-frame
deletion of ctfAB (CoA-transferase) which is
required for acetone production as well as for
acetate and butyrate re-assimilation. These
genes have previously been inactivated by
ClosTron mutagenesis in C. acetobutyli-
cum[23,47] and the fermentation of a ClosTron
ctfA mutant has been studied in continuousE
Mariner transposon
In-frame
deletion/point
mutations
Forward Reverse
Potentially N/A
Yes No
Multiple insertions can be
isolated
Yes
Quick Moderate
tcdRþ pyrE
Requires sensitivity to
thiamphenicol and erythromycin
MIC testing of
5’FOA required
Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
www.advancedsciencenews.com www.biotechnology-journal.comculture.[48] The knock-out of ctfAB in C. beijerinckii NCIMB
14988 caused a reduction in butanol production. However,
chromosomal complementation using the ctfAB genes
expressed from the C. beijerinckii ald and C. sporogenes fdx
promoters failed to fully restore the phenotype of the mutant
strain. Complementation was achieved by plasmid expression
using the C. difﬁcile tcdB promoter. The inability to complement
on the chromosome may be due to a peculiarity of the ctfAB
genes in this context, or a problem with expressing these genes
at this locus, for example a structural aspect,[49] although this is
unlikely.
Intriguingly, it proved impossible to generate a spo0A mutant
inC. beijerinckiiNCIMB 14988 by either allelic exchange or using
the ClosTron. Spo0A is the master regulator of sporulation, and
regulates processes including motility and solvent production
and has previously been inactivated in C. beijerinckii NCIMB
8052.[9,16] Colonies were obtained from transformation with the
suicide vector because the spo0A gene was not disrupted by this
initial integration with the plasmid. In this study bands from
PCR were observed corresponding to a successful KO of the
spo0A gene, but colonies failed to grow when sub-cultured,
suggesting that the spo0A gene may be essential in C. beijerinckii
NCIMB 14988. This has not been reported in any other
organism, and warrants further study.
The ability to use allelic exchange to make point mutations in
the chromosome was demonstrated by the introduction of SNPs
into the ptb gene. Amino acid conservation analysis (Figure 4b)
suggests that apolar aliphatic amino acids are tolerated at these
locations, which might explain why no difference in solvent
production was observed.
In the course of exemplifying ClosTron technology, a
serendipitous discovery was made of an intergenic region, that
when disrupted resulted in a non-sporulating phenotype. Small
RNAs in Bacillus subtilis[50–53] and Clostridium spp.[54,55] have
been identiﬁed but very few have been characterised yet. This
mutant warrants further study.Abbreviations
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